These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27015909)

  • 81. Diagnosis of personality disorders in cocaine-dependent individuals.
    Sonne SC; Brady KT
    Am J Addict; 1998; 7(1):1-6. PubMed ID: 9522001
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cocaine dependence: "Side effects" and syndrome formation within 1-12 months after first cocaine use.
    Chandra M; Anthony JC
    Drug Alcohol Depend; 2020 Jan; 206():107717. PubMed ID: 31753734
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use.
    Fischer B; Kuganesan S; Gallassi A; Malcher-Lopes R; van den Brink W; Wood E
    Int J Drug Policy; 2015 Dec; 26(12):1177-82. PubMed ID: 26500166
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Changing cocaine smoking rituals in the Dutch heroin addict population.
    Grund JP; Adriaans NF; Kaplan CD
    Br J Addict; 1991 Apr; 86(4):439-48. PubMed ID: 2054537
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Pharmacological treatments for heroin and cocaine addiction.
    van den Brink W; van Ree JM
    Eur Neuropsychopharmacol; 2003 Dec; 13(6):476-87. PubMed ID: 14636964
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Heroin maintenance treatment for chronic heroin-dependent individuals: a Cochrane systematic review of effectiveness.
    Ferri M; Davoli M; Perucci CA
    J Subst Abuse Treat; 2006 Jan; 30(1):63-72. PubMed ID: 16377453
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Crack cocaine users views regarding treatment with contingency management in Brazil.
    Miguel AQC; Madruga CS; Simões V; Yamauchi R; da Silva CJ; Abdalla RR; McDonell M; McPherson S; Roll JM; Mari JJ; Laranjeira RR
    Subst Abuse Treat Prev Policy; 2018 Feb; 13(1):7. PubMed ID: 29433535
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Safety and tolerability of intranasal cocaine during phendimetrazine maintenance.
    Stoops WW; Strickland JC; Hays LR; Rayapati AO; Lile JA; Rush CR
    Psychopharmacology (Berl); 2016 Jun; 233(11):2055-2063. PubMed ID: 26932737
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Nasal administration of diacetylmorphine improved the adherence in a patient receiving heroin-assisted treatment.
    Meyer M; Westenberg JN; Strasser J; Dürsteler KM; Lang UE; Krausz M; Vogel M
    Harm Reduct J; 2022 Jun; 19(1):63. PubMed ID: 35672825
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Efficacy of urinalysis in monitoring heroin and cocaine abuse patterns: implications in clinical trials for treatment of drug dependence.
    Cone EJ; Dickerson SL
    NIDA Res Monogr; 1992; 128():46-58; discussion 59-63. PubMed ID: 1436015
    [TBL] [Abstract][Full Text] [Related]  

  • 91. A two-week pilot study of intranasal oxytocin for cocaine-dependent individuals receiving methadone maintenance treatment for opioid use disorder.
    Stauffer CS; Musinipally V; Suen A; Lynch KL; Shapiro B; Woolley JD
    Addict Res Theory; 2016; 24(6):490-498. PubMed ID: 28503120
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effectiveness of incorporating contingency management into a public treatment program for people who use crack cocaine in Brazil. A single-blind randomized controlled trial.
    Miguel AQC; McPherson SM; Simões V; Yamauchi R; Madruga CS; Smith CL; da Silva CJ; Laranjeira RR; McDonell MG; Roll JM; Mari JJ
    Int J Drug Policy; 2022 Jan; 99():103464. PubMed ID: 34619447
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Community treatments for heroin and crack cocaine addiction.
    Bird SM
    Lancet; 2010 Jan; 375(9711):277-8; author reply 278-9. PubMed ID: 20109943
    [No Abstract]   [Full Text] [Related]  

  • 94. Safety and feasibility of intranasal heroin-assisted treatment: 4-week preliminary findings from a Swiss multicentre observational study.
    Vogel M; Meyer M; Westenberg JN; Kormann A; Simon O; Salim Hassan Fadlelseed R; Kurmann M; Bröer R; Devaud N; Sanwald U; Baumgartner S; Binder H; Strasser J; Krausz RM; Beck T; Dürsteler KM; Falcato L
    Harm Reduct J; 2023 Jan; 20(1):2. PubMed ID: 36611162
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
    Palis H; Marchand K; Peachey GS; Westfall J; Lock K; MacDonald S; Jun J; Bojanczyk-Shibata A; Harrison S; Marsh DC; Schechter MT; Oviedo-Joekes E
    Subst Abuse Treat Prev Policy; 2021 Sep; 16(1):68. PubMed ID: 34530878
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Mazindol treatment for cocaine dependence.
    Stine SM; Krystal JH; Kosten TR; Charney DS
    Drug Alcohol Depend; 1995 Oct; 39(3):245-52. PubMed ID: 8556974
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Modafinil Does Not Reduce Cocaine Use in Methadone-Maintained Individuals.
    DeVito EE; Poling J; Babuscio T; Nich C; Carroll KM; Sofuoglu M
    Drug Alcohol Depend Rep; 2022 Mar; 2():. PubMed ID: 36310662
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Efficacy of contingency management for cocaine dependence treatment: a review of the evidence.
    Schierenberg A; van Amsterdam J; van den Brink W; Goudriaan AE
    Curr Drug Abuse Rev; 2012 Dec; 5(4):320-31. PubMed ID: 23244344
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cocaine reduction in unmotivated crack users using carbamazepine versus placebo in a short-term, double-blind crossover design.
    Halikas JA; Crosby RD; Carlson GA; Crea F; Graves NM; Bowers LD
    Clin Pharmacol Ther; 1991 Jul; 50(1):81-95. PubMed ID: 1855356
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Utility of lead-in period in cocaine dependence pharmacotherapy trials.
    Bisaga A; Aharonovich E; Garawi F; Levin FR; Rubin E; Raby WN; Vosburg SK; Nunes EV
    Drug Alcohol Depend; 2005 Jan; 77(1):7-11. PubMed ID: 15607836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.